Kirin Holdings Co. (OTCMKTS:KNBWY) Short Interest Down 62.7% in August

Kirin Holdings Co. (OTCMKTS:KNBWY) was the target of a large decline in short interest in August. As of August 31st, there was short interest totaling 28,981 shares, a decline of 62.7% from the August 15th total of 77,766 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 25,911 shares, the days-to-cover ratio is currently 1.1 days.

Analysts Set New Price Targets

Separately, Zacks Research downgraded Kirin from a “hold” rating to a “strong sell” rating in a research note on Monday, August 31st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Kirin Trading Up 1.8%

Shares of Kirin stock traded up $0.33 during trading hours on Monday, reaching $18.50. 2,757 shares of the company’s stock were exchanged, compared to its average volume of 29,063. Kirin has a 52-week low of $14.01 and a 52-week high of $19.99. The company has a fifty day moving average of $18.54 and a 200-day moving average of $17.26. The company has a current ratio of 1.44, a quick ratio of 1.01 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $14.98 billion, a price-to-earnings ratio of 11.78 and a beta of -0.01.

Kirin (OTCMKTS:KNBWY) last released its quarterly earnings data on Friday, August 7th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.16. The business had revenue of $4.08 billion during the quarter, compared to the consensus estimate of $3.87 billion. Kirin had a return on equity of 12.29% and a net margin of 7.79%. Sell-side analysts forecast that Kirin will post 1.34 EPS for the current fiscal year.

Kirin Company Profile

Kirin Holdings Company, Limited is a Japan-based company with businesses spanning alcoholic and nonalcoholic beverages, pharmaceuticals and health science. Its beverage operations include beer, wine, spirits, soft drinks, bottled water and other consumer products marketed under brands such as Kirin, Ichiban Shibori and Afternoon Tea.

The company’s pharmaceutical business is conducted primarily through Kyowa Kirin, which researches, develops and commercializes prescription medicines, including treatments in areas such as oncology, immunology and nephrology.